It’s shocking how far pharmaceutical companies go to keep drug prices high.

Take, for example, a tactic known as “pay for delay.” It allows pharmaceutical companies to keep cheaper generic versions of their drugs off of the market. This works great for big pharmaceutical corporations, which can cut fat checks to stave off their competition for a while. It’s also a fine deal for generic drug companies, which can reap millions by simply delaying their products’ entry into the market.

Read more: https://www.sacbee.com/opinion/article235764492.html?fbclid=IwAR1Z2mC06F5C5ZOj03d–7FWcVgWmuhzAl5VwC8J-Eql7CgqCoh-DhxgyQE